Learning Objectives:

1.  To understand how donor clonal hematopoiesis impacts recipient outcomes, including relapse, graft-versus-host disease, and donor cell leukemia.

2. To learn about the factors that determine molecular persistence in remission.

3. To gain an appreciation of how recipient germline mutations influence allogeneic transplantation outcomes

Session date: 
02/28/2022 - 12:00pm to 1:00pm CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Coleman Lindsley, MD, PhD